Published 16 days ago

Pfizer can help serious patients: they received the approval to launch the groundbreaking drug onto the market.

Summary by Blikk.hu

Pfizer's first gene therapy treatment for B hemophilia has been approved in the United States. The drug could be introduced in this quarter, with its price of over $3.5 million making it one of the country's most expensive medications.

0 Articles

All

Left

Center

Right

Blikk.hu

Pfizer can help serious patients: they received the approval to launch the groundbreaking drug onto the market.

16 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated16 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Pfizer can help serious patients: they received the approval to launch the groundbreaking drug onto the market.

0 Articles

0 Articles

Pfizer can help serious patients: they received the approval to launch the groundbreaking drug onto the market.

Pfizer can help serious patients: they received the approval to launch the groundbreaking drug onto the market.

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics